Literature DB >> 31355315

Cerebellar ataxia as a presenting symptom in a patient with anti-NMDA receptor encephalitis.

Michiel H F Poorthuis1, Josephus L M van Rooij1, Anna H Koch1, Annelies E M Verdonkschot1, Machteld M Leembruggen1, Maarten J Titulaer1.   

Abstract

Entities:  

Year:  2019        PMID: 31355315      PMCID: PMC6624087          DOI: 10.1212/NXI.0000000000000579

Source DB:  PubMed          Journal:  Neurol Neuroimmunol Neuroinflamm        ISSN: 2332-7812


× No keyword cloud information.
Anti-NMDA receptor (anti-NMDAR) encephalitis is a treatment-responsive autoimmune encephalitis, first described in 2007.[1] Ovarian teratomas are found in one-third of the patients.[2] The clinical features of this disorder vary between patients and age groups and usually include abnormal (psychiatric) behavior or cognitive dysfunction, speech dysfunction (pressured speech, verbal reduction, and mutism), seizures, movement disorders, dyskinesias, or rigidity/abnormal postures, decreased level of consciousness, autonomic dysfunction, or central hypoventilation.[2] Cerebellar ataxia has been described as a symptom during the first months of the disease, especially in young children, in combination with other symptoms.[2,3] It is extremely rare as the initial symptom, especially in adults. We report a case of a female adult with anti-NMDAR encephalitis presenting with cerebellar ataxia associated with recurrent mature ovarian teratomas.

Case report

A 32-year-old woman, born in South Korea and adopted at age 4 months, presented with vertigo, nausea, and vomiting for 4 days. Her medical history consisted of bilateral cystectomy revealing mature teratomas, discovered by ultrasound examination after a missed abortion at age 26 years. During cesarean sections afterward (ages 29 and 31 years), no macroscopic abnormalities were seen. Furthermore, she had had depressive symptoms, treated with venlafaxine for years. Neurologic examination showed a horizontal gaze-evoked nystagmus to the right without other neurologic signs or symptoms. Laboratory investigations on admission were normal, and brain CT showed no abnormalities. Initially, she improved after treatment with antiemetic drugs, but after 3 days, she deteriorated quickly, also complaining of headache. Neurologic examination showed nystagmus in all directions and dysarthric speech (cerebellar) that further worsened to impaired speech restricted to one-word sentences. She showed bilateral dysmetria of the lower and especially the upper limbs, truncal ataxia, and inability to stand and walk. Psychiatric evaluation showed rapid progression of depressive symptoms with suicidal ideation and labile affect. Brain MRI and MRV were normal. CSF analysis and extensive laboratory investigations showed pleocytosis (table). Anti-NMDAR antibodies were negative in serum, but positive in CSF,[4] confirming the diagnosis of definite anti-NMDAR encephalitis.[3]
Table

Overview of investigations

Overview of investigations The patient was treated with IV methylprednisolone 1,000 mg (day 13, 5 days) and IV immunoglobulins 0.4 g/kg (day 16, 5 days). Thorax/abdomen CT and transvaginal ultrasound revealed 2 lesions in the pelvic area with fat tissue and calcifications, suspect for teratomas. Bilateral laparotomic ovariectomy was performed (day 19). Pathologic examination showed mature cystic teratomas, without immature components, containing nervous tissue. Hormone replacement therapy was started. Her neurologic condition improved within a week, but the depressive mood remained. Recovery was hampered by urosepsis, treated with cefuroxime/amoxicillin. She was treated with a second course of methylprednisolone 4 weeks after the initial treatment and immunoglobulins at 8 weeks for remaining speech impairments and severe depression. This resulted in further improvement of both. After 6 weeks, the patient was transferred to a rehabilitation unit. After 6 months, the patient returned home. She was able to perform activities of daily living independently, but needed walking aids outside due to residual ataxia and had not returned to work (yet).

Discussion

This case with cerebellar ataxia as an initial symptom highlights an unusual presentation of anti-NMDAR encephalitis. If cerebellar ataxia is present in patients with anti-NMDAR encephalitis, it is almost exclusively found in (young) children, and most frequently, it appears later in the disease in combination with other symptoms.[2] Different brainstem-cerebellar symptoms have been described, such as opsoclonus-myoclonus syndrome, ocular movement abnormalities, and low cranial nerve involvement in patients with ovarian teratomas, but these symptoms have more frequently been described in whom no NMDAR antibodies could be identified.[5] Although 2 simultaneously occurring paraneoplastic neurologic syndromes, due to an ovarian teratoma, cannot be fully excluded, this is considered unlikely. The development of multiple symptoms quickly into diseases compatible with anti-NMDAR encephalitis (psychiatric symptoms and mutism), the confirmation of NMDAR antibodies by different tests,[4] and the identification of an ovarian teratoma are suitable with a diagnosis of “definite anti-NMDAR encephalitis.”[3] Although it is known that anti-NMDAR IgG antibodies bind to granular cells in the cerebellum (but not to Purkinje cells),[6] it is unknown why only approximately 5% of patients show cerebellar complaints. MRI abnormalities of the cerebellum have been described in 6% of patients.[7] A small study showed progressive cerebellar atrophy by follow-up MRI in 2 of 15 patients with anti-NMDAR encephalitis.[6] In conclusion, cerebellar ataxia is unusual in adult patients and an extremely rare presenting symptom of anti-NMDAR encephalitis. This case shows that anti-NMDAR encephalitis should be considered in the differential diagnosis of cerebellar ataxia, especially in patients with previous teratomas and those developing other symptoms shortly afterward.
  7 in total

1.  Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study.

Authors:  Maarten J Titulaer; Lindsey McCracken; Iñigo Gabilondo; Thaís Armangué; Carol Glaser; Takahiro Iizuka; Lawrence S Honig; Susanne M Benseler; Izumi Kawachi; Eugenia Martinez-Hernandez; Esther Aguilar; Núria Gresa-Arribas; Nicole Ryan-Florance; Abiguei Torrents; Albert Saiz; Myrna R Rosenfeld; Rita Balice-Gordon; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-01-03       Impact factor: 44.182

2.  A novel treatment-responsive encephalitis with frequent opsoclonus and teratoma.

Authors:  Thaís Armangue; Maarten J Titulaer; Lidia Sabater; Javier Pardo-Moreno; Nuria Gresa-Arribas; Natalia Barbero-Bordallo; Gordon R Kelley; Noh Kyung-Ha; Akitoshi Takeda; Takahiro Nagao; Yukitoshi Takahashi; Angélica Lizcano; Aisling S Carr; Francesc Graus; Josep Dalmau
Journal:  Ann Neurol       Date:  2013-09-10       Impact factor: 10.422

3.  Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma.

Authors:  Josep Dalmau; Erdem Tüzün; Hai-yan Wu; Jaime Masjuan; Jeffrey E Rossi; Alfredo Voloschin; Joachim M Baehring; Haruo Shimazaki; Reiji Koide; Dale King; Warren Mason; Lauren H Sansing; Marc A Dichter; Myrna R Rosenfeld; David R Lynch
Journal:  Ann Neurol       Date:  2007-01       Impact factor: 10.422

4.  Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies.

Authors:  Josep Dalmau; Amy J Gleichman; Ethan G Hughes; Jeffrey E Rossi; Xiaoyu Peng; Meizan Lai; Scott K Dessain; Myrna R Rosenfeld; Rita Balice-Gordon; David R Lynch
Journal:  Lancet Neurol       Date:  2008-10-11       Impact factor: 44.182

5.  Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study.

Authors:  Nuria Gresa-Arribas; Maarten J Titulaer; Abiguei Torrents; Esther Aguilar; Lindsey McCracken; Frank Leypoldt; Amy J Gleichman; Rita Balice-Gordon; Myrna R Rosenfeld; David Lynch; Francesc Graus; Josep Dalmau
Journal:  Lancet Neurol       Date:  2013-12-18       Impact factor: 44.182

6.  Association of Progressive Cerebellar Atrophy With Long-term Outcome in Patients With Anti-N-Methyl-d-Aspartate Receptor Encephalitis.

Authors:  Takahiro Iizuka; Juntaro Kaneko; Naomi Tominaga; Hidehiro Someko; Masaaki Nakamura; Daisuke Ishima; Eiji Kitamura; Ray Masuda; Eiichi Oguni; Toshiyuki Yanagisawa; Naomi Kanazawa; Josep Dalmau; Kazutoshi Nishiyama
Journal:  JAMA Neurol       Date:  2016-06-01       Impact factor: 18.302

Review 7.  A clinical approach to diagnosis of autoimmune encephalitis.

Authors:  Francesc Graus; Maarten J Titulaer; Ramani Balu; Susanne Benseler; Christian G Bien; Tania Cellucci; Irene Cortese; Russell C Dale; Jeffrey M Gelfand; Michael Geschwind; Carol A Glaser; Jerome Honnorat; Romana Höftberger; Takahiro Iizuka; Sarosh R Irani; Eric Lancaster; Frank Leypoldt; Harald Prüss; Alexander Rae-Grant; Markus Reindl; Myrna R Rosenfeld; Kevin Rostásy; Albert Saiz; Arun Venkatesan; Angela Vincent; Klaus-Peter Wandinger; Patrick Waters; Josep Dalmau
Journal:  Lancet Neurol       Date:  2016-02-20       Impact factor: 44.182

  7 in total
  6 in total

1.  Voxel-based analysis and multivariate pattern analysis of diffusion tensor imaging study in anti-NMDA receptor encephalitis.

Authors:  Yanli Liang; Luhui Cai; Xia Zhou; Huanjian Huang; Jinou Zheng
Journal:  Neuroradiology       Date:  2019-11-29       Impact factor: 2.804

2.  Isolated Memory Loss in Anti-NMDAR Encephalitis.

Authors:  Raffaele Iorio; Eleonora Sabatelli; Lucia Campetella; Claudia Papi
Journal:  Neurol Neuroimmunol Neuroinflamm       Date:  2021-12-22

3.  Spectrum of Anti-NMDA Receptor Antibody Encephalitis: Clinical Profile, Management and Outcomes.

Authors:  Amlan Kusum Datta; Alak Pandit; Samar Biswas; Atanu Biswas; Biman Kanti Roy; Goutam Gangopaddhyay
Journal:  Ann Indian Acad Neurol       Date:  2021-03-01       Impact factor: 1.383

4.  Stroke-like episodes with cerebellar ataxia as presenting manifestation of adult-onset anti-N-methyl D-aspartate receptor encephalitis: an unusual presentation.

Authors:  Rohan Mahale; M K Farsana; Anitha Mahadevan; Joydeep Mukherjee; Vathsala Lakshmi; M Sandeep; Hansashree Padmanabha; Pooja Mailankody; Mathuranath Pavagada
Journal:  Acta Neurol Belg       Date:  2021-07-03       Impact factor: 2.396

5.  Anti-N-methyl-D-aspartate-receptor antibody encephalitis combined with syphilis: A case report.

Authors:  Xi-Yu Li; Zhi-Hong Shi; Ya-Lin Guan; Yong Ji
Journal:  World J Clin Cases       Date:  2020-06-26       Impact factor: 1.337

6.  Immune-Mediated Cerebellar Ataxia Associated With Neuronal Surface Antibodies.

Authors:  Yu Jia; Mingyu Li; Dawei Li; Mengyao Zhang; Huifang Wang; Lidong Jiao; Zhaoyang Huang; Jing Ye; Aihua Liu; Yuping Wang
Journal:  Front Immunol       Date:  2022-02-17       Impact factor: 7.561

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.